Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

We know that exercise is good for our hearts and overall health. But is that true for people living with heart failure? And ...

agonists in heart failure and chronic kidney disease (CKD) patients was discussed. GLP-1R agonists are cardioprotective in ...

Sitting for over 10 hours or more a day is significantly linked to future heart failure and cardiovascular death risk, a new ...

A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in US patients hospitalized with heart failure (HF) and a left ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Twin sisters living with heart failure are calling for an end to what they say is a postcode lottery when it comes to ...

Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist ...

A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

Heart failure sounds scary - because it is. But here's the thing: millions of Americans are walking around right now with a ...